Aeon Biopharma Inc
AEON0.713USD
+0.033+4.87%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
7.51MMarket Cap
0.04P/E TTM
Aeon Biopharma Inc
0.713
+0.033+4.87%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
Total equity
Cash, cash equivalents and short-term investments
570.47%10.45M
-99.75%13.00K
-96.68%537.00K
32.23%3.44M
--1.56M
--5.16M
--16.18M
--2.60M
- Cash and cash equivalents
570.47%10.45M
-99.75%13.00K
-96.68%537.00K
32.23%3.44M
--1.56M
--5.16M
--16.18M
--2.60M
Prepaid expenses
99.47%1.88M
48.21%1.58M
149.86%1.83M
877.97%577.00K
--940.00K
--1.06M
--734.00K
--59.00K
Total current assets
393.23%12.32M
-74.45%1.59M
-85.98%2.37M
50.98%4.02M
--2.50M
--6.22M
--16.91M
--2.66M
Non-current assets
Net Fixed Assets
186.93%1.45M
156.40%1.52M
136.23%1.60M
120.68%1.69M
--505.00K
--594.00K
--679.00K
--764.00K
-Fixed Assets
147.86%1.73M
134.29%1.79M
124.00%1.85M
115.61%1.91M
--700.00K
--764.00K
--825.00K
--884.00K
-Accumulated depreciation
46.67%286.00K
57.06%267.00K
67.12%244.00K
83.33%220.00K
--195.00K
--170.00K
--146.00K
--120.00K
Other non-current assets
0.00%29.00K
0.00%29.00K
0.00%29.00K
-14.71%29.00K
--29.00K
--29.00K
--29.00K
--34.00K
Total non-current assets
176.78%1.48M
149.12%1.55M
130.65%1.63M
114.91%1.71M
--534.00K
--623.00K
--708.00K
--798.00K
Total assets
355.11%13.80M
-54.10%3.14M
-77.27%4.00M
65.72%5.73M
--3.03M
--6.84M
--17.62M
--3.46M
Liabilities
Current liabilities
-Other payables
-63.50%1.95M
29.21%2.46M
13.25%2.22M
--2.41M
--5.35M
--1.90M
--1.96M
----
Accrued expenses
4.49%4.05M
-24.32%5.66M
-48.95%3.75M
-43.23%4.86M
--3.88M
--7.48M
--7.34M
--8.56M
Short-term debt and lease liabilities
----
----
----
----
----
--0.00
--0.00
--73.43M
Other current liabilities
-63.50%1.95M
29.21%2.46M
13.25%2.22M
--2.41M
--5.35M
--1.90M
--1.96M
----
Total current liabilities
-45.85%8.64M
8.43%14.15M
-24.34%10.73M
-88.19%10.43M
--15.96M
--13.05M
--14.18M
--88.34M
Non-current liabilities
Long-term debt and lease liabilities
183.13%14.40M
--12.83M
31388.46%16.37M
-76.17%14.55M
--5.09M
--0.00
--52.00K
--61.06M
-Long-term debt
161.84%13.32M
--11.69M
--15.17M
-78.19%13.29M
--5.09M
--0.00
--0.00
--60.93M
-Long-term lease liabilities
--1.08M
--1.15M
2215.38%1.20M
870.77%1.26M
----
--0.00
--52.00K
--130.00K
Derivatives liabilities
----
-100.00%0.00
-99.46%264.00K
--345.00K
--250.00K
--41.04M
--48.45M
----
Other non-current liabilities
-98.85%2.08M
-95.53%4.73M
-88.61%8.73M
--8.35M
--180.12M
--105.80M
--76.68M
--0.00
Total non-current liabilities
-91.11%16.48M
-88.04%17.56M
-79.74%25.37M
-61.92%23.25M
--185.46M
--146.84M
--125.18M
--61.06M
Total liabilities
-87.53%25.12M
-80.17%31.71M
-74.10%36.09M
-77.46%33.68M
--201.41M
--159.89M
--139.36M
--149.40M
Shareholders' equity
Common equity
4.56%411.18M
5.71%403.03M
10.90%401.59M
95.48%399.56M
--393.24M
--381.27M
--362.12M
--204.40M
Preferred equity
----
----
----
----
----
----
----
--124.13M
Retained earnings
28.59%-422.50M
8.87%-431.60M
-2.49%-433.68M
15.82%-427.51M
---591.62M
---473.60M
---423.15M
---507.86M
Capital reserves
4.56%411.17M
5.71%403.02M
10.90%401.58M
95.49%399.56M
--393.24M
--381.26M
--362.11M
--204.38M
Less: Treasury stock
----
----
----
----
----
--0.00
----
--23.00K
Non-controlling interests
----
----
----
----
----
--0.00
--0.00
--19.59M
Total equity
94.29%-11.32M
81.33%-28.57M
73.64%-32.09M
80.85%-27.95M
---198.38M
---153.04M
---121.74M
---145.94M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
